The First Cycle: Testosterone Only

Why Testosterone First: And Only Testosterone

The near-universal recommendation from experienced practitioners, harm-reduction communities, and the limited clinical literature on performance-enhancing compound use is unambiguous: the first cycle should be Testosterone only. The recommendation is logically sound, based on what a first cycle is actually for.

A first cycle serves two purposes simultaneously. The first is physiological: to introduce supraphysiological androgens and observe the adaptation. The second, and arguably more important, is informational: to learn how your specific body responds to exogenous testosterone. How much do you aromatize? How does your skin react? How does your blood pressure change? How do your lipids behave? How does your sleep, mood, and aggression shift? These are questions with individual answers, and the only way to gather clean data is to run a single, well-characterised variable.

If you add Dianabol as a kickstart and Nandrolone to the base and then develop gynecomastia in week eight, you have no idea which compound, or which interaction, is driving it. If you develop severe acne on week four, you cannot determine whether it is the Testosterone, the Dianabol, the Nandrolone, or the specific carrier oils in use. Running multiple unknowns on your first cycle does not make the cycle more productive. It makes the data it generates uninterpretable.

Testosterone is also the ideal solo compound because it is anabolic and androgenic in a balanced ratio, it provides a complete hormonal environment (unlike compounds that require test as a base to maintain libido and wellbeing), it aromatizes to estradiol predictably, and its side effect profile is the best-characterised of any compound in this space. Every other compound in existence was compared against Testosterone in whatever clinical or experimental data exists on it. Starting with the benchmark compound is the rational choice.

The gains from testosterone alone are also meaningfully significant for a first-time user. Protein synthesis and nitrogen retention increase substantially above natural levels, which means that at 300–500 mg/week of Testosterone, most beginners will make better gains than they have at any point in their natural training career. There is no need to add complexity to achieve compelling results on a first cycle.

Choosing an Ester: Enanthate vs. Cypionate

For a beginner, the ester choice effectively comes down to Testosterone Enanthate (Test E) versus Testosterone Cypionate (Test C). These two esters are clinically and practically interchangeable for almost all purposes, and the difference between them matters far less than any other variable in your cycle plan. Both have half-lifes of approximately 6–9 days. Both reach steady-state blood levels (known as saturation) at approximately the same rate. Both are typically injected twice weekly.

The primary differences are regional availability and carrier oil conventions. Test Cypionate is the dominant US pharmaceutical testosterone formulation; Enanthate is more common in Europe and international pharmaceutical supply. Underground lab production of both is widespread globally. If you have reliable access to both, choose whichever you can verify is from a more reputable source, ester differences at equivalent doses are functionally negligible.

What you are not selecting as a beginner are short-ester formulations like Testosterone Propionate. Propionate has a half-life of approximately 2–3 days and requires injection EOD (every other day) or even daily ED administration to maintain stable blood levels. This is a meaningful practical burden for someone new to pinning, and the more frequent injection schedule also means higher aggregate injection site trauma and PIP. More importantly, the rapid blood level changes of Propionate make AI management trickier, estradiol rises and falls more steeply between injections, making it harder to calibrate. Long-ester Testosterone for your first cycle is an unambiguous recommendation.

Dosing: The Logic Behind 300–500 mg/Week

The standard beginner dose range of 300–500 mg/week of Testosterone Enanthate or Cypionate is well-established, and the logic behind it deserves understanding rather than simply accepting.

At 300 mg/week, most men achieve blood levels of total testosterone in the range of 1,500–2,500 ng/dL, roughly 3–5× their natural production. At this range, the anabolic signal is meaningfully supraphysiological, but estradiol elevation and side effect burden are relatively modest. Most beginners respond well at this dose and experience substantial gains in strength and lean mass.

At 500 mg/week, testosterone blood levels typically land in the 2,500–4,000+ ng/dL range. The anabolic return is higher, but so is aromatization to estradiol, the need for AI management, and the stress on hematocrit and lipid profiles. The dose-response curve for anabolic effect is not linear above a certain point, going from 300 to 500 mg/week does not produce proportionally more muscle than going from 0 to 300. The incremental benefit above 400 mg/week for a first-cycle beginner is modest relative to the incremental risk.

A reasonable heuristic: if you are cautious by nature, want to minimise AI complexity, and prioritise information gathering over maximum gains on your first run, start at 300–350 mg/week. If you are comfortable with the monitoring requirements, have your estradiol management plan in place, and want more pronounced first-cycle results, 400–500 mg/week is well within the established beginner range. Going above 500 mg/week on a first cycle has no clear justification, you are adding risk to a situation where you have insufficient data about your own response to inform the decision.

The split of your weekly dose across two injections is standard practice for long-ester testosterone. 500 mg/week becomes 250 mg Monday/Thursday, or any similar arrangement that spaces injections roughly 3–4 days apart. Even spacing maintains more consistent blood levels and reduces peak-to-trough variation in estradiol, which simplifies AI dosing decisions.

Care checkpoints and individual follow-up

A fixed calendar cannot tell you when side effects will appear or when hormonal recovery will occur. The compound, duration of exposure, health history, symptoms, and test results all affect the assessment. These checkpoints describe the questions that need attention, without setting a cycle length or treatment schedule.

Changes in performance and wellbeing

Strength, body weight, libido, and recovery between workouts can change during use. Scale weight also reflects water and glycogen, so it cannot show how much muscle has been gained or will be retained. A week-by-week forecast gives more certainty than these observations support.

Side effects can appear at different times. Acne, breast changes, sleep disruption, and changes in mood warrant attention. Some health changes are not obvious from how you feel, which is one reason symptoms and appropriately interpreted measurements both matter.

Symptoms that need prompt care

Do not wait for a planned test or appointment if you develop chest pain, severe shortness of breath, stroke-like symptoms, or thoughts of self-harm. Seek urgent medical help. Tell the clinician what you have taken and when, including other medicines or substances.

Recovery and baseline information

External androgens suppress natural testosterone production. After stopping, low mood, fatigue, or sexual symptoms can occur, and recovery varies. PCT does not guarantee recovery or restored fertility. Persistent or severe symptoms need medical assessment rather than assumptions about a standard recovery window.

A baseline medical assessment gives later results context. Depending on your history, this may include blood pressure, a blood count, lipids, liver and kidney markers, and hormone tests. Review abnormal findings before considering exposure. A normal panel cannot certify that a cycle is safe.

The readiness lesson covers the decision before use, and the bloodwork reference explains common markers. Test selection, follow-up timing, and treatment decisions belong in an individual clinical assessment.